Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823264 · ClinicalTrials.gov registry record · NA
Phenytoin and Multidose Activated Charcoal
A NA study of Phenytoin Toxicity, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT00823264 is a NA study of Phenytoin Toxicity that has completed, run by Emory University. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00823264, a NA study of Phenytoin Toxicity, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
Phenytoin is a medicine used to treat seizures. If too much is taken, patients have ill effects including sleepiness, unsteady gait, and eye problems. The amount of drug in their system can be measured in their blood. Charcoal is a medicine that can absorb phenytoin. We want to see if giving multiple doses of charcoal will quicken the removal of phenytoin from the blood. This is theorized to occur as charcoal absorbs phenytoin from across the intestines and then is secreted in the stool. Patients will be selected to receive either charcoal in multiple doses or no charcoal and their serum levels will be drawn repeatedly to follow their level. The different groups will then be compared to see if multidose charcoal does indeed increase the elimination of phenytoin from the body.
Conditions Studied
Interventions
- DRUG Activated Charcoal
Study Locations (1)
Georgia
- Grady Memorial Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00823264
The ClinicalTrials.gov registry entry for NCT00823264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Phenytoin Toxicity appearing as the primary indexed condition, and to 1 intervention - of which Activated Charcoal is the first listed.
NCT00823264 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00823264 about?
NCT00823264 is a clinical study titled "Phenytoin and Multidose Activated Charcoal". Phenytoin is a medicine used to treat seizures. If too much is taken, patients have ill effects including sleepiness, unsteady gait, and eye problems. The amount of drug in their system can be measured in their blood. Charcoal is a medicine that can absorb phenytoin. We want to see if giving multipl...
What is the current status of trial NCT00823264?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2008-08. Estimated completion is 2012-01.
What conditions does trial NCT00823264 study?
This clinical trial studies the following conditions: Phenytoin Toxicity.
What interventions are being tested in trial NCT00823264?
The interventions under investigation include: Activated Charcoal (DRUG).
Who is sponsoring clinical trial NCT00823264?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00823264 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.